31 results
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
standard identifiers SLN, NPI, DEA #s for initial and ongoing data validation.
(3)Usage of data hygiene scrub – for HCP demographic data
8-K
EX-99.1
eea iol1tsl
7 Nov 22
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
xvus 8i1n7n55lr
11 Aug 22
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
mbe xaiyxyxm34m5nve
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-1.1
87sfuvae qnr
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
8-K
EX-99.1
69wgvhh5z3vyg2c
30 Mar 22
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
4:19pm
8-K
EX-1.1
76sdz4fnum i3msews8
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-1.1
masz yxo8j
18 Mar 21
Entry into a Material Definitive Agreement
5:13pm